Laura Qm C.

Interim Chief Medical Officer @Tallac Therapeutics

Austin, TX, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Apr 2024 — Present

Interim Chief Medical Officer @Tallac Therapeutics

View department →

Working with novel TLR9 antibody conjugate. Trial design and strategy, medical monitoring and safety, executive, board, investor presentations.

EDUCATION

2002 — 2004

University of Calgary, Tom Baker Cancer Center

Medical Oncology Fellowship

1999 — 2002

University of Alberta

Internal Medicine Residency

1995 — 1999

The University of British Columbia

MD, Medicine

1994 — 1995

Université de Montréal

French as a Second Language

1990 — 1994

The University of British Columbia

B.Sc, First class honors in pharmacology and therapeutics

2004 — 2006

University of Colorado Anschutz

developmental therapeutics, early phase clinical trials, translational oncology, lung and GI cancers

ABOUT LAURA QM C.

22+ years of expertise in drug development with knowledge spanning: Preclinical R/D…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Laura Qm C. — Interim Chief Medical Officer at Tallac Therapeutics in Austin, TX, US | Unifers